InterStim™ Micro system Rechargeable neurostimulator for bladder and bowel control
The InterStim™ Micro system features the smallest rechargeable implantable neurostimulator for sacral neuromodulation.
DOWNLOAD BROCHURE
Overview
More control
At 2.8cm3, the InterStim™ Micro neurostimulator is the smallest sacral neuromodulation device on the market. It is designed to deliver the same effective results as the trusted InterStim™ II system for people with bladder and bowel control problems.
PRODUCT DETAILS
Overdrive™ technology
Not all batteries are created equal. The InterStim™ Micro is smaller, better, faster, and stronger than all other manufacturers’ batteries.
- At 2.8 cm3, the InterStim™ Micro neurostimulator is the smallest sacral neuromodulation device on the market.
- No battery fade at 15 years*
- Recharge in 20 minutes, once a week†
- Recharge from zero to 100% in less than an hour‡
- Patients can restart their therapy after an extended break
MRI eligibility
The InterStim™ Micro system, including the InterStim™ SureScan™ MRI lead, has FDA-approved labeling for full-body§ 1.5 and 3 Tesla MRI scans. Refer to the MRI guidelines for a complete list of conditions and instructions for use (available in the Medtronic Manuals Library).
Proprietary SureScan™ MRI technology expands eligibility and allows patients with either InterStim™ system to get full-body§ MRI scans.
SureScan™ MRI technology is a known and trusted brand by MRI technicians. This allows for a convenient, streamlined, and simple MRI workflow.
Manuals and technical guides
Access prescriber, implant, MRI, and other manuals in the Medtronic Manual Library. Search by product name (InterStim™) or model number (97810). Or call 800-961-9055 for a copy of a manual.
MODEL SPECIFICATIONS
|
Model |
97810 |
|---|---|
|
Battery type |
Rechargeable |
|
Weight |
7.3 g |
|
Height |
17 mm |
|
Length |
47 mm |
|
System components |
Full implant components
Advanced evaluation components
|
The most common adverse events experienced during clinical studies include pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms.
Show patients
the way
The care pathway helps patients envision their journey to relief, so they know what to expect and can keep moving forward.
Learn moreSay yes to the test
Learn the parameters of patient selection for bladder control and bowel control.
VIEW TOOLS
*
Under standard patient therapy settings.
†
Under standard patient therapy settings and appropriate recharger placement.
‡
Based on appropriate recharger placement.
§
Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI leads only.